Travere Therapeutics, Inc. · NASDAQ:TVTX
Inrig Jula sold 8,233 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 13 to Apr 15, 2026 · Filed Apr 15, 2026
From Apr 13 to Apr 15, 2026, Inrig Jula (CHIEF MEDICAL OFFICER) sold 8,233 Travere Therapeutics, Inc. shares at an average US$42.01 for US$346K under a trading plan, leaving 111,473 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 8,233 shares
- Price
- US$42.01 average (US$41.93 to US$42.61)
- Value
- US$346K
- Holding after
- 111,473 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Award | 14,000 | 119,706 | Direct | |
| Apr 14, 2026 | Common Stock | Sale | 7,215 | US$41.93 | 112,491 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 1,018 | US$42.61 | 111,473 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Inrig Jula
- Travere Therapeutics, Inc. shareholders
- Form 4 · Inrig Jula · Sep 17, 2026
- Form 4 · Inrig Jula · Jun 22, 2026
- Form 4 · Inrig Jula · May 6, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026